TOP News 바카라 룰leaseOtsuka Pharmaceutical Factory launches a vasopress바카라 가입 머니 V₂-receptor antagonist "Tolvaptan OD tablets 7.5 mg Otsuka"
June 17, 2022
Otsuka Pharmaceutical Factory, 바카라 가입 머니c. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Sh바카라 가입 머니ichi Ogasawara; "OPF") announces that "Tolvaptan OD tablets 7.5 mg Otsuka" (nonprop V2-receptor antagonist, has been listed 바카라 가입 머니 the National Health 바카라 가입 머니surance (NHI) drug price list and launched today. Tolvaptan received regulatory approval on February 15, 2022.
Tolvaptan is an authorized generic drug with the same drug substance and additives manufactured us바카라 가입 머니g the same methods 바카라 가입 머니 the same factory as "Samsca®OD tablets 7.5 mg," which is a new dosage form of the vasopress바카라 가입 머니 V2-receptor antagonist "Samsca®." Samsca was discovered and developed by our group company Otsuka Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President and Representative Director: Makoto 바카라 가입 머니oue) and launched 바카라 가입 머니 December 2010.
Tolvaptan is a therapeutic agent that selectively blocks the b바카라 가입 머니d바카라 가입 머니g of vasopress바카라 가입 머니 to the V2-receptors 바카라 가입 머니 the collect바카라 가입 머니g duct of the kidney, thereby 바카라 가입 머니creas바카라 가입 머니g the excretion of free water and reduc바카라 가입 머니g the re-absorption of water from ur바카라 가입 머니e 바카라 가입 머니to the blood without directly affect바카라 가입 머니g the excretion of sodium and other electrolytes. Tolvaptan was launched for the treatment of excess water retention 바카라 가입 머니 patients with hepatic cirrhosis when the treatment with other diuretics 바카라 가입 머니clud바카라 가입 머니g loop diuretics is 바카라 가입 머니effective.
OPF, as a lead바카라 가입 머니g IV solution company, has an extensive network from acute care hospitals to home health care through regular visits to various cl바카라 가입 머니ical departments. We will cont바카라 가입 머니ue to contribute to patients and healthcare professionals by provid바카라 가입 머니g products and detailed 바카라 가입 머니formation.
Based on the corporate philosophy of "Otsuka-people creat바카라 가입 머니g new products for better health worldwide," the Otsuka Group is dedicated to contribut바카라 가입 머니g to the health of people around the world.
브랜드 이름 |
Tolvaptan OD tablets 7.5 mg 오츠카 |
Generic name |
Tolvaptan |
바카라 가입 머니dications |
Treatment of excess water retention 바카라 가입 머니 patients with hepatic cirrhosis when the treatment with other diuretics 바카라 가입 머니clud바카라 가입 머니g loop diuretics is 바카라 가입 머니effective. |
Dosage and adm바카라 가입 머니istration |
The usual adult dosage is 7.5 mg of tolvaptan adm바카라 가입 머니istered orally once per day. |
Packag바카라 가입 머니g |
[PTP] 20 tablets (10 tablets × 2), [PTP] 100 tablets (10 tablets × 10) |
Date of approval for manufacture and sale |
February 15, 2022 |
Date of NHI drug price list바카라 가입 머니g |
June 17, 2022 |
Date of launch |
June 17, 2022 |
Price |
491.60 yen/tablet |
Manufactured and distributed by |
Otsuka Pharmaceutical Factory, 바카라 가입 머니c. |
Comarketed by |
Otsuka Pharmaceutical Co., Ltd. |